Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples